Tipifarnib in Treating Patients With Advanced Hematologic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase I trial to study the effectiveness of tipifarnib in treating patients who
have advanced hematologic cancer. Drugs used in chemotherapy use different ways to stop
cancer cells from dividing so they stop growing or die.